Skip to content
Dry Powder Inhalation Capsule (DPI) Allopathic

Indarol Plus 27.5 mcg+15.6 mcg dry powder inhalation capsule (dpi)

Generic: Indacaterol + Glycopyrronium

Company: Healthcare Pharmaceuticals Ltd.. Prices are as listed on BestinMeds; your pharmacy price may differ.

Strength27.5 mcg+15.6 mcg
PackStrip: 200.00 taka

Reviewed by: not listed yet. Source: not listed yet.

Last updated December 21, 2025.

Compare

Same generic, same strength

Sorted by price per dry powder inhalation capsule (dpi). Ask your pharmacist before you switch brands.

Indacaterol + Glycopyrronium 27.5 mcg+15.6 mcg dry powder inhalation capsule (dpi)s

Prices as listed on BestinMeds.

1 brand listed
Indarol Plus (this medicine)20.00 taka per dry powder inhalation capsule (dpi)

Advertisement

Google Ads 970 x 250
Google Ads 300 x 250
Medicine guide

About this medicine

What this medicine is for, how to take it, and what to watch for.

Read the full Indacaterol + Glycopyrronium guide

Indications

COPD Indacaterol & Glycopyrronium combination is indicated for the long-term, maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD).

Dosage and administration

Indacaterol 110 µg and Glycopyrronium 50 µg: The recommended dosage of Indacaterol & Glycopyrronium combination DPI is inhalation of the contents of one capsule once daily with the ConviHaler device. Indacaterol 27.5 µg & Glycopyrronium 15.6 µg: The recommended dosage of Indacaterol & Glycopyrronium combination DPI is inhalation of the contents of one capsule twice daily with the ConviHaler device.

Side effects

Inhaled medicines may cause inhalation-induced bronchospasm, dehydration, dry mouth, constipation dizziness, insomnia, skin and subcutaneous tissue disorders & immune system disorders.

Precautions and warnings

Indacaterol and Glycopyrronium combination is as a twice daily maintenance bronchodilator should not be used for the initial treatment of acute episodes of bronchospasm, i.e. rescue therapy. Immediate hypersensitivity reactions may occur after administration of Indacaterol and Glycopyrronium combination inhalation powder. As with other anticholinergic drugs, Glycopyrronium should be used with caution in patients with narrow-angle glaucoma, prostatic hyperplasia or bladder-neck obstruction.

Pregnancy and lactation

There is a limited amount of data from the use of Indacaterol and Glycopyrronium combination in pregnant women. Animal studies do not indicate direct or indirect harmful effects with respect to reproductive toxicity at clinically relevant doses. Indacaterol and Glycopyrronium combination should not be used in pregnant or nursing women unless the expected benefit outweighs any possible risk to the unborn child or the infant.

Clinical details

BestinMeds shares medicine information to help you compare. It does not replace advice from your doctor or pharmacist.

Advertisement

Google Ads 970 x 250
Google Ads 300 x 250

Advertisement

Google Ads 970 x 250
Google Ads 300 x 250